BONESUPPORT will create its own U.S. commercial organization to support current and future U.S. product launches. Direct sales will commence in October 2018.
In a study comparing expandable and static LLIF devices, at 2-year follow-up, researchers observed no implant subsidence in patients treated with expandable devices, with 16% subsidence in levels treated with static spacers.